Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Spider Med Oy
OY
Active
Y-tunnus 3155019-5
Iso Roobertinkatu 41-B8
Dental practice care activities · NACE 8623
Est. 2020
99 employees
www.spidermed.fi
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
EUR 13,3M
+9% vs 2023
EBITDA margin
4.8%
-50% vs 2023
Equity ratio
54.7%
Financial strength
Net profit 2024
EUR -29K
-104% vs 2023
EBITDA — year on year
EUR millions
1M
1M
1M
0M
0M
1M
2021
1M
0%
2022
1M
0%
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
EUR 13,3M
+9%
EBITDA
EUR 638K
-50%
Net profit
EUR -29K
-104%
Total assets
EUR 3,9M
+22%
Equity
EUR 2,1M
+221%
Employees
99
—
Company information
Legal name
Spider Med Oy
Y-tunnus number
3155019-5
Legal form
Osakeyhtiö
NACE code
8623 · Dental practice care activities
Founded
31. elokuuta 2020
Share capital
EUR 0
Employees
99 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsen yksin
Company purpose
86 Terveyspalvelut
Contact
Address
Iso Roobertinkatu 41-B8
Phone
+3580407212737
Email
joona.iso-lotila@spidermed.fi
Website
www.spidermed.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Dental practice care activities
Companies in Helsinki
All Finland companies
Revenue
EUR millions
0M
4M
7M
11M
15M
2M
2021
8M
2022
12M
2023
13M
2024
EBITDA
EUR millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
Income statement
EUR thousands
Item
2021
2022
2023
2024
Revenue
2 285
8 346
12 252
13 323
Staff expenses
−1 440
−5 635
−7 964
−8 015
EBITDA
521
1 427
1 273
638
Depreciation & amort.
−63
−334
−415
−673
EBIT
459
1 093
859
−35
Net financials
−1
−0
−26
6
Profit before tax
457
653
833
−29
Tax
91
219
167
−0
Net profit
366
434
666
−29
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
Total assets
825
2 818
3 218
3 911
Equity
366
434
666
2 138
Long-term debt
—
—
1 001
0
Short-term debt
459
2 384
1 532
1 773
Total debt
459
2 384
2 552
1 773
Financial ratios
5-year trend
EBITDA margin
4.8%
This company
15.8%
Market median
-70% vs market
2021
2024
Equity ratio
54.7%
This company
38.2%
Market median
+43% vs market
2021
2024
Return on equity
-1.4%
This company
18.4%
Market median
-108% vs market
2021
2024
Net profit margin
-0.2%
This company
8.1%
Market median
-102% vs market
2021
2024
Asset turnover
3.41×
This company
1.12×
Market median
+204% vs market
2021
2024
Debt / equity
0.83×
This company
0.62×
Market median
+34% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-08-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
JR
Joona Risto Mikael Iso-Lotila
Chief Executive Officer
Chief Executive Officer
2022
Former (2)
VA
Ville Antti Valkonen
Deputy auditor
Deputy auditor
2022 – 2024
AM
Antti Mikael Koponen
Audit
Audit
2022 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
AE
Arttu Eerikki Rissanen
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Spider Med Oy also hold positions in
0
other companies.
Person
Role here
Other companies
Ville Antti Valkonen
Deputy auditor
0 companies
Antti Mikael Koponen
Audit
0 companies
Joona Risto Mikael Iso-Lotila
Chief Executive Officer
0 companies
Arttu Eerikki Rissanen
Board of Directors
0 companies